Preparticipation cardiac screening in athletes: still a diamond in the rough? - Takeaways - MDSpire

Preparticipation cardiac screening in athletes: still a diamond in the rough?

  • By

  • Aaron Baggish

  • October 14, 2025

  • 0 min

Share

  • 1

    Preparticipation screening (PPS) for cardiovascular disease in athletes is widely recommended but remains controversial regarding its implementation.

  • 2

    A study analyzed 111,062 PPS exams, revealing that 7.6% required further evaluation, with higher abnormal rates in older athletes.

  • 3

    Only 0.34% of athletes were classified with high-risk cardiovascular conditions, with prevalence increasing with age.

  • 4

    The cost of PPS and second-line evaluations varied by age, being lowest for young athletes (€60) and highest for those over 35 (€107).

  • 5

    The study highlights the need for robust data to evaluate the effectiveness and resource utilization of PPS in competitive athletes.

Original Source(s)

Preparticipation cardiac screening in athletes: still a diamond in the rough?

  • by Aaron Baggish

  • October 14, 2025

Related Content

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.

NPs Top US Jobs List Again

The nurse practitioner profession claims the No. 1 spot across three categories in the U.S. News & World Report 2026 Best Jobs rankings for the third consecutive year.

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.